Tamid-001

N/A

Report date: 2025/01/26 15:56:15

Base Information

Drug NameTamid-001
Drug Alias NameAAV gene therapy (Tamid/University of North Carolina)AAV8G9-opt-IDUAalpha-L-iduronidase stimulating AAV gene therapy (Tamid Bio)
ClassificationBiologics
Mechanisms of ActionAlpha-L-iduronidase stimulants
TargetsAlpha-L-iduronidase
Therapy Area/IndicationsMucopolysaccharidosis I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina, Greensboro
China Registration ClassN/A

Develop Information

Active CompaniesTamid Bio Inc
Inactive CompaniesUniversity Of North Carolina, Greensboro
Active IndicationsMucopolysaccharidosis I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A